PT690132E - Anticorpo monoclonal anti-hiv - Google Patents
Anticorpo monoclonal anti-hivInfo
- Publication number
- PT690132E PT690132E PT94909286T PT94909286T PT690132E PT 690132 E PT690132 E PT 690132E PT 94909286 T PT94909286 T PT 94909286T PT 94909286 T PT94909286 T PT 94909286T PT 690132 E PT690132 E PT 690132E
- Authority
- PT
- Portugal
- Prior art keywords
- region
- antibody
- hiv
- monoclonal antibody
- pnd
- Prior art date
Links
- 230000036436 anti-hiv Effects 0.000 title abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108010047041 Complementarity Determining Regions Proteins 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7891393 | 1993-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT690132E true PT690132E (pt) | 2004-04-30 |
Family
ID=13675093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94909286T PT690132E (pt) | 1993-03-11 | 1994-03-09 | Anticorpo monoclonal anti-hiv |
Country Status (11)
Country | Link |
---|---|
US (1) | US6114143A (pt) |
EP (1) | EP0690132B1 (pt) |
JP (1) | JP3855071B2 (pt) |
KR (1) | KR100337069B1 (pt) |
AT (1) | ATE256751T1 (pt) |
AU (1) | AU681633B2 (pt) |
DE (1) | DE69433422T2 (pt) |
DK (1) | DK0690132T3 (pt) |
ES (1) | ES2213148T3 (pt) |
PT (1) | PT690132E (pt) |
WO (1) | WO1994020632A1 (pt) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2443330A1 (en) * | 2001-04-05 | 2002-10-17 | Toshimitsu Uede | Anti-osteopontin antibody and use thereof |
KR100423614B1 (ko) * | 2001-05-16 | 2004-03-22 | 주식회사유한양행 | 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자 |
KR20040048899A (ko) | 2001-09-25 | 2004-06-10 | 가부시키가이샤 멘에키세이부츠 켄큐죠 | 재조합 항-오스테오폰틴 항체 및 그의 용도 |
US7153509B2 (en) | 2001-11-07 | 2006-12-26 | Duke University | Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope |
US7172761B2 (en) * | 2001-11-07 | 2007-02-06 | Duke University | Polyvalent immunogen |
US7195768B2 (en) * | 2001-11-07 | 2007-03-27 | Duke University | Polyvalent immunogen |
US7041499B2 (en) * | 2001-12-12 | 2006-05-09 | University Of North Texas Health Science Center | Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth |
CN1659225B (zh) * | 2002-04-12 | 2012-06-27 | Mba聚合物公司 | 包含回收塑料的组合物 |
AU2003241103A1 (en) * | 2002-04-23 | 2003-11-10 | Umberto Dianzani | Compositions containing anti-hiv peptides and methods of use |
US8332159B2 (en) * | 2003-02-20 | 2012-12-11 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Method for enhancing efficacy of preparation of monoclonal antibody |
US20050014230A1 (en) * | 2003-07-16 | 2005-01-20 | Ccl Holding Co., Ltd. | Preparation of fully human antibodies |
US7807157B2 (en) | 2004-02-20 | 2010-10-05 | Intellect Neurosciences Inc. | Monoclonal antibodies and use thereof |
JP2009509970A (ja) * | 2005-09-22 | 2009-03-12 | プロサイ インコーポレイテッド | 酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法 |
KR20090024748A (ko) | 2006-05-31 | 2009-03-09 | 아스텔라스세이야쿠 가부시키가이샤 | 인간화 항인간 오스테오폰틴 항체 |
JP5440179B2 (ja) | 2008-01-11 | 2014-03-12 | アステラス製薬株式会社 | 改良型ヒト化抗ヒトα9インテグリン抗体 |
US20110300068A1 (en) | 2009-01-12 | 2011-12-08 | Takeda Pharmaceutical Company Limited | Agent for prophylaxis or treatment of cancer |
JP5726165B2 (ja) | 2010-03-11 | 2015-05-27 | 株式会社 資生堂 | アオウキクサ由来の新規リポキシゲナーゼ |
EP2550362B1 (en) | 2010-03-25 | 2017-01-04 | Oregon Health&Science University | Cmv glycoproteins and recombinant vectors |
JP5726172B2 (ja) | 2010-03-31 | 2015-05-27 | 株式会社 資生堂 | アオウキクサ由来の新規アレンオキサイドシンターゼ |
TW201249867A (en) | 2011-04-01 | 2012-12-16 | Astellas Pharma Inc | Novel anti-human il-23 receptor antibody |
CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
ME02944B (me) | 2011-08-11 | 2018-04-20 | Astellas Pharma Inc | Novo antitelo protiv humanog ngf |
AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
AR089425A1 (es) | 2011-12-22 | 2014-08-20 | Astellas Pharma Inc | Anticuerpo ctgf (factor de crecimiento de tejido conectivo) antihumano |
US9371391B2 (en) | 2012-02-28 | 2016-06-21 | Astellas Pharma Inc. | Anti-human IL-23 receptor antibody and encoding polynucleotides |
EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
SG11201600935SA (en) | 2013-08-09 | 2016-03-30 | Astellas Pharma Inc | Novel anti-human tslp receptor antibody |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
EP3088519A4 (en) | 2013-12-24 | 2017-09-13 | Astellas Pharma Inc. | Novel anti-human bdca-2 antibody |
EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
US9925258B2 (en) | 2015-10-02 | 2018-03-27 | International Aids Vaccine Initiative | Replication-competent VSV-HIV Env vaccines |
CA3102859A1 (en) | 2018-07-03 | 2020-01-09 | Gilead Sciences, Inc. | Antibodies that target hiv gp120 and methods of use |
JP2021534093A (ja) | 2018-08-20 | 2021-12-09 | 江蘇恒瑞医薬股▲ふん▼有限公司 | 腫瘍処置用医薬の製造におけるtim−3抗体の使用 |
US20220002389A1 (en) * | 2018-10-29 | 2022-01-06 | Immuno-Biological Laboratories Co., Ltd. | Anti-hiv antibody and method for producing same |
IL282650B1 (en) | 2018-10-31 | 2024-05-01 | Astellas Pharma Inc | Anti-human FN14 antibody |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
DE3853779T2 (de) * | 1987-05-29 | 1995-09-07 | Baylor College Medicine | Hiv-1 neutralisierende monoklonale antikörper. |
EP0339504A3 (en) * | 1988-04-26 | 1990-09-12 | The Du Pont Merck Pharmaceutical Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
EP0436634A1 (en) * | 1988-10-03 | 1991-07-17 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
WO1990015078A1 (en) * | 1989-06-05 | 1990-12-13 | Scott Charles F Jr | HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120 |
RU2128222C1 (ru) * | 1991-08-22 | 1999-03-27 | Ниссин Сокухин Кабусики Кайся | Мышиное моноклональное антитело nm01, гибридомная клеточная линия, фрагмент мышиного могоклонального антитела (варианты) |
-
1994
- 1994-03-09 EP EP94909286A patent/EP0690132B1/en not_active Expired - Lifetime
- 1994-03-09 WO PCT/JP1994/000371 patent/WO1994020632A1/ja active IP Right Grant
- 1994-03-09 KR KR1019950703809A patent/KR100337069B1/ko active IP Right Grant
- 1994-03-09 DE DE69433422T patent/DE69433422T2/de not_active Expired - Lifetime
- 1994-03-09 PT PT94909286T patent/PT690132E/pt unknown
- 1994-03-09 JP JP51982494A patent/JP3855071B2/ja not_active Expired - Lifetime
- 1994-03-09 ES ES94909286T patent/ES2213148T3/es not_active Expired - Lifetime
- 1994-03-09 US US08/513,968 patent/US6114143A/en not_active Expired - Lifetime
- 1994-03-09 AT AT94909286T patent/ATE256751T1/de not_active IP Right Cessation
- 1994-03-09 AU AU62194/94A patent/AU681633B2/en not_active Expired
- 1994-03-09 DK DK94909286T patent/DK0690132T3/da active
Also Published As
Publication number | Publication date |
---|---|
AU681633B2 (en) | 1997-09-04 |
WO1994020632A1 (en) | 1994-09-15 |
DE69433422D1 (de) | 2004-01-29 |
KR960701214A (ko) | 1996-02-24 |
ATE256751T1 (de) | 2004-01-15 |
EP0690132B1 (en) | 2003-12-17 |
KR100337069B1 (ko) | 2002-10-11 |
DK0690132T3 (da) | 2004-04-13 |
EP0690132A1 (en) | 1996-01-03 |
EP0690132A4 (en) | 1998-07-29 |
AU6219494A (en) | 1994-09-26 |
DE69433422T2 (de) | 2004-09-16 |
US6114143A (en) | 2000-09-05 |
JP3855071B2 (ja) | 2006-12-06 |
ES2213148T3 (es) | 2004-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69433422D1 (de) | Monoklonaler anti-hiv antikörper | |
PT100195A (pt) | Anticorpos monoclonais quimericos e humanos que se ligam a epitopos de receptores de factor de crescimento da epiderme, seus vectores de expressao, processo de preparacao e composicoes farmaceuticas que os contem | |
CA2091263A1 (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
PT678523E (pt) | Anticorpos recombinantes anti-vih e sua preparacao | |
DK0492560T3 (da) | Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider | |
KR930702509A (ko) | 사람 면역결핍 바이러스(hiv)면역치료제 | |
RU2004108115A (ru) | Рекомбинантные антитела и композиции, а также способы их создания и использования | |
ES2059577T3 (es) | Fragmentos genicos que codifican para las regiones variables de un anticuerpo anti-hiv, anticuerpos anti-hiv quimericos expresados utilizando los mismos y procedimiento para su preparacion. | |
ATA171686A (de) | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen | |
RU94045907A (ru) | Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты | |
DK0516135T3 (da) | Humant immundefektvirus-relateret immunpræparat | |
KR890016165A (ko) | 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도 | |
EP0511300A1 (en) | Monoclonal antibody specific for non-immunodominant epitope of hiv proteins | |
CA2157874A1 (en) | Anti-hiv monoclonal antibody | |
RU2007140569A (ru) | Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич, но не в отношении il2 | |
DE69113520D1 (de) | Monoklonale Antikörper gegen HIV GP120. | |
RU2021136626A (ru) | АНТИТЕЛО К EphA4 | |
RU2007140570A (ru) | Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич | |
DE68913932D1 (de) | Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung. | |
DK0470989T3 (da) | Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer | |
KR20040000401A (ko) | Hiv 바이러스에 대한 천연 항체 | |
KR960700274A (ko) | 재조합 항-hiv 항체 및 그의 제조방법[recombinant anti-hiv antibody and preparation thereof] | |
BR9711809A (pt) | Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo | |
RU93004854A (ru) | Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека |